$1.52
0.03[2.01%]
Last update: 8:24AM Get Real Time Here
Unity Biotechnology
(NASDAQ:UBX)Unity Biotechnology Stock (NASDAQ:UBX), Earnings Estimates, EPS, and Revenue
Unity Biotechnology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.510
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Unity Biotechnology using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | PM | UBX | Q1 | -$0.76 | -$0.51 | — | — | $0.00 | — | — | — | Get Alert |
| 04/15/2024 | AM | UBX | Q4 | -$1.00 | -$0.72 | -$0.28 | 61.11% | $0.00 | — | $0.00 | — | Get Alert |
| 11/13/2023 | PM | UBX | Q3 | -$1.36 | -$0.92 | -$0.67 | 27.17% | $0.00 | — | $0.00 | — | Get Alert |
| 08/08/2023 | PM | UBX | Q2 | -$1.90 | -$0.86 | -$0.85 | 1.16% | $236.00K | — | $0.00 | — | Get Alert |
| 05/09/2023 | PM | UBX | Q1 | -$2.80 | -$1.08 | -$0.76 | 29.63% | $0.00 | — | $0.00 | — | Get Alert |
| 03/15/2023 | PM | UBX | Q4 | -$1.80 | -$1.05 | -$1.00 | 4.76% | $4.78M | — | $0.00 | — | Get Alert |
| 11/08/2022 | PM | UBX | Q3 | -$3.00 | -$1.65 | -$1.36 | 17.58% | $0.00 | — | $0.00 | — | Get Alert |
| 08/12/2022 | PM | UBX | Q2 | -$3.20 | -$2.70 | -$1.90 | 29.63% | $0.00 | — | $236.00K | — | Get Alert |
| 05/10/2022 | PM | UBX | Q1 | -$2.90 | -$2.60 | -$2.80 | -7.69% | $0.00 | — | $0.00 | — | Get Alert |
| 03/15/2022 | AM | UBX | Q4 | -$3.70 | -$3.80 | -$1.80 | 52.63% | $0.00 | — | $4.78M | — | Get Alert |
| 11/10/2021 | PM | UBX | Q3 | -$5.20 | — | -$3.00 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/10/2021 | PM | UBX | Q2 | -$3.80 | -$3.10 | -$3.20 | -3.23% | $0.00 | — | $0.00 | — | Get Alert |
| 05/11/2021 | PM | UBX | Q1 | -$5.90 | -$3.80 | -$2.90 | 23.68% | $0.00 | — | $0.00 | — | Get Alert |
| 03/23/2021 | PM | UBX | Q4 | -$3.90 | -$4.70 | -$3.70 | 21.28% | $0.00 | — | $0.00 | — | Get Alert |
| 11/04/2020 | PM | UBX | Q3 | -$5.10 | -$4.90 | -$5.20 | -6.12% | $0.00 | — | $0.00 | — | Get Alert |
| 07/31/2020 | AM | UBX | Q2 | -$5.60 | -$5.10 | -$3.80 | 25.49% | $0.00 | — | $0.00 | — | Get Alert |
| 05/07/2020 | PM | UBX | Q1 | -$4.40 | -$5.10 | -$5.90 | -15.69% | $0.00 | — | $0.00 | — | Get Alert |
| 03/11/2020 | PM | UBX | Q4 | -$5.30 | -$5.60 | -$3.90 | 30.36% | $0.00 | — | $0.00 | — | Get Alert |
| 11/06/2019 | PM | UBX | Q3 | -$4.50 | -$5.10 | -$5.10 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
FAQ
When is Unity Biotechnology (NASDAQ:UBX) reporting earnings?
Unity Biotechnology (UBX) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on April 15, 2024 for Q4.
What were the latest earnings per share (EPS) for Unity Biotechnology (NASDAQ:UBX)?
The Actual EPS was $-0.28, which beat the estimate of $-0.72.
What were Unity Biotechnology’s (NASDAQ:UBX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.